P-280: Transition from severe insulin resistance to autoimmune insulin deficiency in a child with polyglandular autoimmunity: a metabolic–autoimmune endotype
Hormone Research in Paediatrics · 04.11.2026 · 99 (Supplement_4)
DOI: 10.1159/hrp/adaag020.338 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone Research in Paediatrics, online erschienen am 04.11.2026. Verfasst von C Tatiana und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
The coexistence of insulin resistance and pancreatic autoimmunity in children represents an emerging metabolic–immune endotype that challenges the traditional distinction between type 1 and type 2 diabetes. Some pediatric patients exhibit a hybrid phenotype combining autoimmune β-cell destruction with marked insulin resistance. Familial clustering of autoimmune and metabolic disorders may contribute to this complex presentation.
Objectives
To describe the longitudinal metabolic and immunologic evolution of a pediatric patient progressing from severe insulin resistance to overt autoimmune diabetes in the context of familial polyautoimmunity.
Methods
We conducted a longitudinal clinical analysis of a boy diagnosed with autoimmune thyroiditis at age 11 and treated with levothyroxine. Serial evaluations included fasting glucose, HbA1c, insulin, C-peptide, HOMA-IR, pancreatic autoantibodies (anti-GAD, anti-insulin, IA-2), thyroid antibodies, lipid profile, renal parameters, and vitamin D levels. A four-generation pedigree was constructed to assess familial clustering of autoimmune and metabolic diseases.
Results
At 12 years and 9 months, the patient had obesity, impaired fasting glucose, marked hyperinsulinemia, and insulin resistance (HbA1c 5.7%). Over 18 months, glucose increased to 237 mg/dL and HbA1c to 9.3%. C-peptide declined from 11 to 0.75 ng/mL, indicating β-cell failure. Anti-GAD and anti-insulin antibodies were strongly positive, with persistent thyroid autoimmunity and vitamin D deficiency. Insulin therapy achieved suboptimal control. Family history revealed clustering of diabetes and autoimmune diseases.
Conclusions
This case shows progression from insulin resistance to autoimmune β-cell failure. Elevated anti-GAD and anti-insulin antibodies suggest an intermediate autoimmune phase before insulin dependence, highlighting the need for early family screening and integrated monitoring.
Zitieren
APA
Tatiana, C., & Mihai, C. M. (2026). P-280: Transition from severe insulin resistance to autoimmune insulin deficiency in a child with polyglandular autoimmunity: a metabolic–autoimmune endotype. Hormone Research in Paediatrics, 99(Supplement_4). https://doi.org/10.1159/hrp/adaag020.338
Vancouver
Tatiana C, Mihai CM. P-280: Transition from severe insulin resistance to autoimmune insulin deficiency in a child with polyglandular autoimmunity: a metabolic–autoimmune endotype. Hormone Research in Paediatrics. 2026;99(Supplement_4). doi:10.1159/hrp/adaag020.338
BibTeX
@article{Tatiana2026,
author = {Tatiana, C and Mihai, C M},
title = {P-280: Transition from severe insulin resistance to autoimmune insulin deficiency in a child with polyglandular autoimmunity: a metabolic–autoimmune endotype},
journal = {Hormone Research in Paediatrics},
year = {2026},
volume = {99},
number = {Supplement_4},
doi = {10.1159/hrp/adaag020.338}
}
EUVIMED